The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension.

<h4>Background</h4>A number of studies have reported the association between the use of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin-II receptor blocker (ARB) medications and the occurrence or severity of coronavirus disease 2019 (COVID-19). Published results are inconc...

Full description

Bibliographic Details
Main Authors: Mingfei Li, Ying Wang, Ndindam Ndiwane, Michelle B Orner, Natalia Palacios, Brant Mittler, Dan Berlowitz, Lewis E Kazis, Weiming Xia
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0248652

Internet

https://doi.org/10.1371/journal.pone.0248652

Similar Items